meningitis final

Upload: shielamaygo05

Post on 02-Jun-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 Meningitis Final

    1/22

    MENINGITIS

    Galvez, Cindel Paulen Feliz

    Go, Shiela May

    Lamzon, Mary Pauline

  • 8/10/2019 Meningitis Final

    2/22

    Meningitisis an inflammation of the

    membranes (meninges) surrounding yourbrain and spinal cord.

    Common causes of meningitis may include: Bacteria, Virus, Fungi and Parasites.

    Most episodes of meningitis result from

    hematogenous seeding of infection fromother sites to the meninges.

  • 8/10/2019 Meningitis Final

    3/22

    Causative Agents

    Type Pathogen (most Common)

    Bacterial Strep pneumoniae,Neisseriameningitis

    Viral infection Coxsackie Virus, Echovirus, Arbovirus,

    HIV,

    TB meningitis M. Tuberculosis

    Protozoal Infection Toxoplasma Gondii (toxoplasmosis)

    Fungal infection Cryptococcus neoformans (cryptococcalmeningitis)

  • 8/10/2019 Meningitis Final

    4/22

    Signs and Symptoms

    Fever Severe, persistent

    headache

    Neck stiffness and pain

    that makes it difficult totouch your chin to yourchest

    Nausea and vomiting

    Confusion anddisorientation

    Drowsiness orsluggishness

    Sensitivity to bright light Poor appetite

    More severe symptomsinclude seizure and coma

    In infants, symptoms mayinclude fever, irritability,poor feeding, andlethargy.

    Skin rashRapid breathing

  • 8/10/2019 Meningitis Final

    5/22

    DIAGNOSTIC EXAM

    1. CSF

    Lumbar puncture or a shunt tap is performed as

    soon as the diagnosis of meningitis is suspected.

    CSF should be examined for:

    Microbiology and

    Biochemistry

  • 8/10/2019 Meningitis Final

    6/22

    2. C-Reactive protein (CRP).

    3. Blood culture and other cultures (urine,

    abscess, and middle ear).

    4. Full Blood Picture (CBC) and ESR.

    5. Serum electrolytes, BUN, Creatinine.

    6. Urine test, to check for infection in theurinary tract.

  • 8/10/2019 Meningitis Final

    7/22

    6.Other examinations

    Electro encephalogram (EEG) if seizures areprominent.

    Head imaging (CT). Indications for CT are:

    (CT scan or MRI, to look for swelling of brain tissue or

    for complications such as brain damage.)

    Focal neurological examination findings, Seizures,

    Increasing head circumference,

    Lack of improvement despite appropriate treatment

    and Suspected brain abscess.

    CT should only be done when the patient is stable.

  • 8/10/2019 Meningitis Final

    8/22

    CHAIN OF TRANSMISSION

    HUMANNASAL AND

    BUCCAL

    SECRETION

    DIRECTLY: touching,

    kissing, coughing,

    sneezing, etc

    INDIRCTLY:

    contaminating a formite

    then handing it off

    NOSE

    AND

    MOUTH

    YOUNG CHILDREN ,

    IMMUNOCOMPRO

    MISED PERSON,

    elderly people

  • 8/10/2019 Meningitis Final

    9/22

    WHO ARE AT RISK?

    Age -- Most cases of viral meningitis occur in childrenyounger than age 5. Bacterial meningitis commonlyaffects people under 20, especially those living incommunity settings.

    Living in a community setting -- College students livingin dormitories, personnel on military bases, andchildren in boarding schools and child care facilities areat increased risk of meningococcal meningitis. This

    increased risk likely occurs because the bacterium isspread by the respiratory route and tends to spreadquickly wherever large groups congregate.

  • 8/10/2019 Meningitis Final

    10/22

    Skipping vaccinations --If you or your child

    hasn't completed the recommended

    childhood or adult vaccination schedule, therisk of meningitis is higher.

    Pregnancy -- If you're pregnant, you're at

    increased risk of contracting listeriosis aninfection caused by listeria bacteria, which

    also may cause meningitis. If you have

    listeriosis, your unborn baby is at risk, too.

  • 8/10/2019 Meningitis Final

    11/22

    Compromised immune system -- Factors that

    may compromise your immune system

    including AIDS, alcoholism, diabetes and use

    of immunosuppressant drugs also make

    you more susceptible to meningitis. Removal

    of your spleen, an important part of your

    immune system, also may increase your risk

  • 8/10/2019 Meningitis Final

    12/22

    PREVELANCE/INCIDENCE

    Approximately 70 percent of meningitis cases occur inchildren under the age of 5 and in people over the age of 60. In

    the United States, bacterial meningitis affects about 4,000

    people each year, and viral meningitis affects about 10 people

    in 100,000. Hib vaccine has reduced U.S. incidence of bacterial

    meningitiscaused byHaemophilus influenzaetype b by

    approximately 90 percent. The disease is more prevalent in

    people between the ages of 15 and 24 who have not been

    vaccinated.

    Worldwide, bacterial resistance to penicillin and other

    antibiotics and the lack of access to vaccines accounts for

    rising rates of bacterial meningitis.

  • 8/10/2019 Meningitis Final

    13/22

    PREVELANCE/INCIDENCE

    Childhood meningitis in the conjugate vaccine

    era: a prospective cohort studyManish Sadarangani1, Louise Willis1, Seilesh Kadambari2, Stuart Gormley3, Zoe

    Young1, Rebecca Beckley1, Katherine Gantlett1, Katharine Orf4, Sarah

    Blakey4, Natalie G Martin1, Dominic F Kelly1, Paul T Heath2, Simon

    Nadel3, Andrew J Pollard1

    http://adc.bmj.com/search?author1=Manish+Sadarangani&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Louise+Willis&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Seilesh+Kadambari&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Zoe+Young&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Zoe+Young&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Rebecca+Beckley&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Katherine+Gantlett&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Katharine+Orf&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Sarah+Blakey&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Sarah+Blakey&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Natalie+G+Martin&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Dominic+F+Kelly&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Paul+T+Heath&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Simon+Nadel&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Simon+Nadel&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Andrew+J+Pollard&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Andrew+J+Pollard&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Simon+Nadel&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Simon+Nadel&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Paul+T+Heath&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Dominic+F+Kelly&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Natalie+G+Martin&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Sarah+Blakey&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Sarah+Blakey&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Katharine+Orf&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Katherine+Gantlett&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Rebecca+Beckley&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Zoe+Young&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Zoe+Young&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Seilesh+Kadambari&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Seilesh+Kadambari&sortspec=date&submit=Submithttp://adc.bmj.com/search?author1=Seilesh+Kadambari&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Louise+Willis&sortspec=date&submit=Submithttp://adc.bmj.com/content/early/2014/09/25/archdischild-2014-306813.abstracthttp://adc.bmj.com/search?author1=Manish+Sadarangani&sortspec=date&submit=Submit
  • 8/10/2019 Meningitis Final

    14/22

    Abstract

    Bacterial conjugate vaccines have dramatically changed

    the epidemiology of childhood meningitis; viral causes areincreasingly predominant, but the current UK epidemiology isunknown. This prospective study recruited children under16 years of age admitted to 3 UK hospitals with suspectedmeningitis. 70/388 children had meningitis13 bacterial, 26viral and 29 with no pathogen identified. Group BStreptococcus was the most common bacterial pathogen.Infants under 3 months of age with bacterial meningitis weremore likely to have a reduced Glasgow Coma Score andrespiratory distress than those with viral meningitis or otherinfections. There were no discriminatory clinical features in

    older children. Cerebrospinal fluid (CSF) white blood cellcount and plasma C-reactive protein at all ages, and CSFprotein in infants

  • 8/10/2019 Meningitis Final

    15/22

    PATHOPYSIOLOGY

  • 8/10/2019 Meningitis Final

    16/22

    Entry of basophils and

    macrophages

    Accumulation of fluid

    and pus

    InflamationFever

    Entry of virus/bacteria to the

    nasopharyngeal area

    Non-Modifiable Risk Factors:

    - Age

    Modifiable Risk Factors:

    Environment

    Immune system

    Poor hygiene

    Invasion of virus/bacteria to the

    respiratory tract: cough

    Accumulates to blood stream goingto the brain and spine

    Virus/bacteria colonize in the

    Cerebro Spinal Fluid and Meninges

    Release pyrogenic cytokines

    Goes to blood vessle and signals the brain

    Stimulates hypothalamus to

    increase thermostats

    Destruction of cells in the meninges

    Release of chemical mediators: cytokin,

    pyrogen

    Menigeal irritabil ity

    Pain: headache

  • 8/10/2019 Meningitis Final

    17/22

    Blank

    Staring

    Increased Intracrainal

    pressure

    Compression of brain and

    Spine: Altered motor activity

    Compression of Pons,

    hypothalamus,

    cerebrum

    comaDrowziness

    Compressed

    Thoracic 6 (T6)

    Stomach

    upset:vomitting

    Compressed

    Cervical 2 (C2)

    Stiff neck

  • 8/10/2019 Meningitis Final

    18/22

    MEDICAL INTERVENTION

    1)Give antibiotic treatment as soon as possible ( e.g.

    Ampicillin plus Cefotaxime, Chloramphenicol plus

    Ampicillin,Chloramphenicol plus Benzyl penicillin)

    2)Give antipyretic drug if fever is present.

    3)IV Fluids

    4)Anticonvulsant if convulsing.

    5)Medicines to treat pressure on the brain.(mannitol,

    dexamethasone)

  • 8/10/2019 Meningitis Final

    19/22

    NURSING DIAGNOSIS

    Deficient fluid volume related to increase

    intracranial pressure as evidenced by

    vomiting, altered level of consciousness, poor

    skin turgor, dry lips, dry buccal mucosa.

  • 8/10/2019 Meningitis Final

    20/22

    Monitor vital signs(temp.,RR,PR)

    Monitor Input/output

    Monitor IV fluids very carefully and examinefrequently for signs of fluid overload

    Increase fLuid intake

    Oral care Observe standard precautions to prevent dse.

    transmission.

  • 8/10/2019 Meningitis Final

    21/22

    NURSING DIAGNOSIS

    Hyperthermia related to inflammation of

    meninges as evidenced by skin is warm to

    touch, irritability, weak in appearance,

    increase CSF WBC

  • 8/10/2019 Meningitis Final

    22/22

    NURSING INTERVENTION

    Monitor vital signs(temperature)

    Provide tepid sponge bath and cold compress

    Increase fluid intake

    Change clothing to loose and comfortable ones

    after seizure roll pt. to side/semiprone-facilitate

    gravity, drainage of secretions.

    administer antibiotics with strict administration

    schedule.